Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer

<p>Abstract</p> <p>Background</p> <p>The VEGF family of ligands and receptors are intimately involved in tumor angiogenesis, lymphangiogenesis and metastasis. The evaluation of VEGF ligand/receptor ratios may provide a more profound understanding of the involvement of t...

Full description

Bibliographic Details
Main Authors: Terracciano Luigi, Baumhoer Daniel, Zlobec Inti, Eppenberger Manuela, Lugli Alessandro
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/93
_version_ 1811315383203790848
author Terracciano Luigi
Baumhoer Daniel
Zlobec Inti
Eppenberger Manuela
Lugli Alessandro
author_facet Terracciano Luigi
Baumhoer Daniel
Zlobec Inti
Eppenberger Manuela
Lugli Alessandro
author_sort Terracciano Luigi
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The VEGF family of ligands and receptors are intimately involved in tumor angiogenesis, lymphangiogenesis and metastasis. The evaluation of VEGF ligand/receptor ratios may provide a more profound understanding of the involvement of these proteins in colorectal tumour progression. The aim of this study was to elucidate the role of the VEGF ligand/receptor ratios on tumour progression and metastasis in patients with mismatch repair-proficient colorectal cancer.</p> <p>Methods</p> <p>Immunohistochemistry for VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGFR1, VEGFR2 and VEGF3 was carried out on 387 mismatch repair-proficient colorectal cancers using a tissue microarray. Evaluation of immunoreactivity was performed semi-quantitatively and the ligand/receptor expression ratio was obtained.</p> <p>Results</p> <p>An increased VEGF-A/VEGFR1 ratio, VEGF-A and VEGFR1 was linked to the presence of peritumoral lymphocytic inflammation at the invasive front (p = 0.032; p = 0.005; p = 0.032, respectively). VEGFR1 expression was related to poorer outcome in multivariable analysis with pT stage, pN stage, vascular invasion, and post-operative therapy. A higher ratio of VEGF-A/VEGFR2 was linked to advanced TNM stage (p = 0.005) while VEGF-A and VEGFR2 were elevated in tumours with an infiltrating tumour growth pattern (p = 0.006; p = 0.014; p = 0.006). No effect of VEGF-A/VEGFR2, VEGF-A or VEGFR2 on survival time was noted.</p> <p>Conclusions</p> <p>Our findings highlight an involvement of VEGF-A, VEGR1 and VEGFR2 in events occurring at the invasive tumour front and a potential prognostic role of VEGFR1 expression in mismatch repair-proficient colorectal cancers. The VEGF-A ligand to VEGFR1 or VEGFR2 ratio may represent an alternative evaluation system for identifying patients with poorer clinical outcome.</p>
first_indexed 2024-04-13T11:29:22Z
format Article
id doaj.art-212051db2f42405c894166ccd5e187cb
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-13T11:29:22Z
publishDate 2010-03-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-212051db2f42405c894166ccd5e187cb2022-12-22T02:48:36ZengBMCBMC Cancer1471-24072010-03-011019310.1186/1471-2407-10-93Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancerTerracciano LuigiBaumhoer DanielZlobec IntiEppenberger ManuelaLugli Alessandro<p>Abstract</p> <p>Background</p> <p>The VEGF family of ligands and receptors are intimately involved in tumor angiogenesis, lymphangiogenesis and metastasis. The evaluation of VEGF ligand/receptor ratios may provide a more profound understanding of the involvement of these proteins in colorectal tumour progression. The aim of this study was to elucidate the role of the VEGF ligand/receptor ratios on tumour progression and metastasis in patients with mismatch repair-proficient colorectal cancer.</p> <p>Methods</p> <p>Immunohistochemistry for VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGFR1, VEGFR2 and VEGF3 was carried out on 387 mismatch repair-proficient colorectal cancers using a tissue microarray. Evaluation of immunoreactivity was performed semi-quantitatively and the ligand/receptor expression ratio was obtained.</p> <p>Results</p> <p>An increased VEGF-A/VEGFR1 ratio, VEGF-A and VEGFR1 was linked to the presence of peritumoral lymphocytic inflammation at the invasive front (p = 0.032; p = 0.005; p = 0.032, respectively). VEGFR1 expression was related to poorer outcome in multivariable analysis with pT stage, pN stage, vascular invasion, and post-operative therapy. A higher ratio of VEGF-A/VEGFR2 was linked to advanced TNM stage (p = 0.005) while VEGF-A and VEGFR2 were elevated in tumours with an infiltrating tumour growth pattern (p = 0.006; p = 0.014; p = 0.006). No effect of VEGF-A/VEGFR2, VEGF-A or VEGFR2 on survival time was noted.</p> <p>Conclusions</p> <p>Our findings highlight an involvement of VEGF-A, VEGR1 and VEGFR2 in events occurring at the invasive tumour front and a potential prognostic role of VEGFR1 expression in mismatch repair-proficient colorectal cancers. The VEGF-A ligand to VEGFR1 or VEGFR2 ratio may represent an alternative evaluation system for identifying patients with poorer clinical outcome.</p>http://www.biomedcentral.com/1471-2407/10/93
spellingShingle Terracciano Luigi
Baumhoer Daniel
Zlobec Inti
Eppenberger Manuela
Lugli Alessandro
Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
BMC Cancer
title Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
title_full Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
title_fullStr Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
title_full_unstemmed Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
title_short Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
title_sort role of the vegf ligand to receptor ratio in the progression of mismatch repair proficient colorectal cancer
url http://www.biomedcentral.com/1471-2407/10/93
work_keys_str_mv AT terraccianoluigi roleofthevegfligandtoreceptorratiointheprogressionofmismatchrepairproficientcolorectalcancer
AT baumhoerdaniel roleofthevegfligandtoreceptorratiointheprogressionofmismatchrepairproficientcolorectalcancer
AT zlobecinti roleofthevegfligandtoreceptorratiointheprogressionofmismatchrepairproficientcolorectalcancer
AT eppenbergermanuela roleofthevegfligandtoreceptorratiointheprogressionofmismatchrepairproficientcolorectalcancer
AT luglialessandro roleofthevegfligandtoreceptorratiointheprogressionofmismatchrepairproficientcolorectalcancer